Bruker Corp (BRKRP) community

BRKRPNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BRKR

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30428% above fair value

$442.19−17.24 (-3.75%)

Close on Nov 12, 2026Market cap $9.36BP/E –Yield –

Community

Notes and questions about Bruker from other investors

No posts about BRKRP yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Where these numbers come from

Parsed from the XBRL in Bruker's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BRKRP.

Compare: BRKRP vs WAT · BRKRP vs BIO · BRKRP vs RVTY · BRKRP vs MTD · BRKRP vs ILMN

Revenue growth2.2% · median 5.8%

Gross margin47.7% · median 60.4%

Operating margin-2.0% · median 8.7%

Net margin-3.5% · median 19.7%

Company	Revenue	Growth
WAT	$5.61B	+80.7%
ILMN	$4.54B	+5.8%
MTD	$4.20B	+6.5%
BRKRP	$3.51B	+2.2%
RVTY	$2.94B	+4.6%
BIO	$2.59B	+1.4%

Company

Next earnings (est.): Feb 11, 2027, before open
Exchange: Nasdaq
Industry: Laboratory Analytical Instruments
Fiscal year ends: December 31
Employees: 11,085
Auditor: PricewaterhouseCoopers LLP
SEC CIK: 1109354

Advertisement
300 × 250

See a number that looks wrong?